Review

interoperable cgm dexcom g6 (Dexcom Inc)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Dexcom Inc interoperable cgm dexcom g6
Interoperable Cgm Dexcom G6, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interoperable+cgm+dexcom+g6/interoperable+glucose+sensor+dexcom+g6/pm39951268-75-7-11
Average 90 stars, based on 1 article reviews

interoperable cgm dexcom g6 - by Bioz Stars, 2026-09

90/100 stars

Images

other:

Article Title: Automated Insulin Delivery in Adults With Type 2 Diabetes
Article Snippet: When used in Automated Mode with an interoperable CGM (study CGM: Dexcom G6), the AID algorithm delivers dynamic microboluses of insulin every 5 minutes or pauses insulin based on glucose values to approach the user configurable target glucose value of 110 mg/dL to 150 mg/dL in 10mg/dL increments, adjustable by time of day (to convert glucose to micromoles per liter, multiply by 0.0555).

Article Title: Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy
Article Snippet: This outpatient study consisted of a standard therapy phase followed by phases in which participants used the investigational device, which included a tubeless insulin pump with an embedded proprietary AID algorithm (Omnipod 5; Insulet Corporation, Acton, MA), an interoperable CGM (Dexcom G6; Dexcom Inc., San Diego, CA), and a mobile application (Omnipod 5 app) on a locked-down Android phone ( , ).

Article Title: Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy.
Article Snippet: This outpatient study consisted of a standard therapy phase followed by phases in which participants used the investigational device, which included a tubeless insulin pump with an embedded proprietary AID algorithm (Omnipod 5; Insulet Corporation, Acton, MA), an interoperable CGM (Dexcom G6; Dexcom Inc., San Diego, CA), and a mobile application (Omnipod 5 app) on a locked-down Android phone (23,24).

Article Title: Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical Trial.
Article Snippet: When used in Automated Mode with an interoperable CGM (study CGM: Dexcom G6), the AID algorithm delivers dynamic microboluses of insulin every 5 minutes or pauses insulin based on glucose values to approach the user configurable target glucose value of 110 mg/dL to 150 mg/dL in 10mg/dL increments, adjustable by time of day (to convert glucose to micromoles per liter, multiply by 0.0555).14

Image Search Results

Components of the commercially intended Omnipod 5 Automated Insulin Delivery System. From left to right: (1) tubeless insulin pump (Pod) containing the automated insulin delivery algorithm (52 × 39 × 14.5 mm without adhesive, 26 g when empty); (2) Omnipod 5 application (app), pictured running on provided locked-down smartphone handheld device (144 × 67.6 × 12.4 mm, 165 g); (3) interoperable CGM (Dexcom G6, see Dexcom product documentation for additional information). The Pod is a lightweight, waterproof (IP28), self-adhesive insulin pump that delivers insulin through an automatically inserted cannula. The automated insulin delivery algorithm is built into the Pod, which receives glucose measurements every 5 min directly from the on-body CGM. The algorithm then commands the Pod to deliver microboluses every five minutes based on current and projected glucose values, with the goal of achieving and maintaining a set target glucose value. The user interacts with the system through the Omnipod 5 app, which communicates with the Pod through Bluetooth ® wireless technology. Actions performed using the app include: complete initial setup, activate and deactivate Pods, start Automated Mode, use the bolus calculator, deliver insulin boluses, enable the HypoProtect feature, view insulin delivery and CGM history, respond to system alerts and alarms, check Pod status, and adjust settable parameters. The app home screen (pictured) prominently displays the current CGM value and trend, as well as the amount of insulin on board, information about the last bolus, and a link to view the CGM history graph. The bolus calculator is accessed using the circular icon near the bottom of the screen. Since the algorithm runs on the Pod, and the Pod and CGM are both worn on-body and communicate directly, automated insulin delivery can continue uninterrupted even if the handheld device containing the app is not nearby. Copyrighted image used with permission. © 2020 Insulet Corporation. All rights reserved. CGM, continuous glucose monitor.

Journal: Diabetes Technology & Therapeutics

Article Title: First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes

doi: 10.1089/dia.2020.0546

Figure Lengend Snippet: Components of the commercially intended Omnipod 5 Automated Insulin Delivery System. From left to right: (1) tubeless insulin pump (Pod) containing the automated insulin delivery algorithm (52 × 39 × 14.5 mm without adhesive, 26 g when empty); (2) Omnipod 5 application (app), pictured running on provided locked-down smartphone handheld device (144 × 67.6 × 12.4 mm, 165 g); (3) interoperable CGM (Dexcom G6, see Dexcom product documentation for additional information). The Pod is a lightweight, waterproof (IP28), self-adhesive insulin pump that delivers insulin through an automatically inserted cannula. The automated insulin delivery algorithm is built into the Pod, which receives glucose measurements every 5 min directly from the on-body CGM. The algorithm then commands the Pod to deliver microboluses every five minutes based on current and projected glucose values, with the goal of achieving and maintaining a set target glucose value. The user interacts with the system through the Omnipod 5 app, which communicates with the Pod through Bluetooth ® wireless technology. Actions performed using the app include: complete initial setup, activate and deactivate Pods, start Automated Mode, use the bolus calculator, deliver insulin boluses, enable the HypoProtect feature, view insulin delivery and CGM history, respond to system alerts and alarms, check Pod status, and adjust settable parameters. The app home screen (pictured) prominently displays the current CGM value and trend, as well as the amount of insulin on board, information about the last bolus, and a link to view the CGM history graph. The bolus calculator is accessed using the circular icon near the bottom of the screen. Since the algorithm runs on the Pod, and the Pod and CGM are both worn on-body and communicate directly, automated insulin delivery can continue uninterrupted even if the handheld device containing the app is not nearby. Copyrighted image used with permission. © 2020 Insulet Corporation. All rights reserved. CGM, continuous glucose monitor.

Article Snippet: The Omnipod 5 Automated Insulin Delivery System (Omnipod 5) consists of the tubeless insulin pump (Pod) integrated with an interoperable CGM (Dexcom G6), and the Omnipod 5 mobile application (app) ( ).

Techniques: Adhesive